Why do antiviral drugs target specific steps in the viral life cycle?

• A. Because viruses replicate independently of the host cell, targeting them is easy.
• B. Because antivirals target host cell machinery to kill host cells.
• C. Because viruses replicate by hijacking host cell machinery; antivirals target steps like entry, replication, or release to block replication with selective toxicity.
• D. Because antiviral drugs are always non-specific and target all cellular processes.

Answer: (C)

The idea being tested is selective targeting of viral processes to stop replication without harming the host cell. Viruses can only reproduce by using the host cell’s machinery, so antiviral drugs are designed to interfere with specific steps in the viral life cycle—such as entry into the cell, genome replication, or the release of new viral particles. By focusing on steps or viral enzymes that are essential and distinct from normal host cell functions, these drugs achieve selective toxicity: they block viral replication while minimizing damage to the host.

This approach works because many antiviral strategies target viral proteins or steps that have no exact equivalent in human cells, or that are uniquely important to the virus. For example, blocking viral entry prevents the virus from getting inside; inhibiting a viral polymerase stops genome replication; blocking a viral protease prevents proper maturation of viral proteins. In contrast, the other statements rely on concepts that aren’t accurate—viruses do not replicate independently of host cells, antivirals are not designed to kill host cells by targeting host machinery, and antivirals are not inherently non-specific to cellular processes.